List of Array Biopharma Inc. patents

Patents where

Current Assignee

Name

Array Biopharma Inc.

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10172861 Crystalline form of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-A]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfate	Patent 10172861 was granted and assigned to Array Biopharma Inc. on January, 2019 by the United States Patent and Trademark Office.	Array Biopharma Inc.	Array Biopharma Inc.	United States Patent and Trademark Office	10172861	January 8, 2019
‌ US Patent 7799782 P38 inhibitors and methods of use thereof	Patent 7799782 was granted and assigned to Array Biopharma Inc. on September, 2010 by the United States Patent and Trademark Office.		Array Biopharma Inc.	United States Patent and Trademark Office	7799782	September 21, 2010
‌ US Patent 10485788 Pharmaceutical combinations	Patent 10485788 was granted and assigned to Array Biopharma Inc. on November, 2019 by the United States Patent and Trademark Office.	Array Biopharma Inc.	Array Biopharma Inc.	United States Patent and Trademark Office	10485788	November 26, 2019
‌ US Patent 9457093 Solid dispersions of a ERB2 (HER2) inhibitor	Patent 9457093 was granted and assigned to Array Biopharma Inc. on October, 2016 by the United States Patent and Trademark Office.	Array Biopharma Inc.	Array Biopharma Inc.	United States Patent and Trademark Office	9457093	October 4, 2016
‌ US Patent 11376239 Pharmaceutical combinations	Patent 11376239 was granted and assigned to Array Biopharma Inc. on July, 2022 by the United States Patent and Trademark Office.	Array Biopharma Inc.	Array Biopharma Inc.	United States Patent and Trademark Office	11376239	July 5, 2022
‌ US Patent 8933084 Macrocyclic compounds as Trk kinase inhibitors	Patent 8933084 was granted and assigned to Array Biopharma Inc. on January, 2015 by the United States Patent and Trademark Office.		Array Biopharma Inc.	United States Patent and Trademark Office	8933084	January 13, 2015
‌ US Patent 10548894 Combination therapy	Patent 10548894 was granted and assigned to Array Biopharma Inc. on February, 2020 by the United States Patent and Trademark Office.	Array Biopharma Inc.	Array Biopharma Inc.	United States Patent and Trademark Office	10548894	February 4, 2020
‌ US Patent 9365568 Pyrrolopyridines as kinase inhibitors	Patent 9365568 was granted and assigned to Array Biopharma Inc. on June, 2016 by the United States Patent and Trademark Office.	Array Biopharma Inc.	Array Biopharma Inc.	United States Patent and Trademark Office	9365568	June 14, 2016
‌ US Patent 8981085 Pyrrolopyridines as kinase inhibitors	Patent 8981085 was granted and assigned to Array Biopharma Inc. on March, 2015 by the United States Patent and Trademark Office.	Array Biopharma Inc.	Array Biopharma Inc.	United States Patent and Trademark Office	8981085	March 17, 2015
‌ US Patent 9750744 Macrocyclic compounds as Trk kinase inhibitors	Patent 9750744 was granted and assigned to Array Biopharma Inc. on September, 2017 by the United States Patent and Trademark Office.	Array Biopharma Inc.	Array Biopharma Inc.	United States Patent and Trademark Office	9750744	September 5, 2017
‌ US Patent 10112942 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors	Patent 10112942 was granted and assigned to Array Biopharma Inc. on October, 2018 by the United States Patent and Trademark Office.	Array Biopharma Inc.	Array Biopharma Inc.	United States Patent and Trademark Office	10112942	October 30, 2018
‌ US Patent 10441581 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors	Patent 10441581 was granted and assigned to Array Biopharma Inc. on October, 2019 by the United States Patent and Trademark Office.	Array Biopharma Inc.	Array Biopharma Inc.	United States Patent and Trademark Office	10441581	October 15, 2019
‌ US Patent 9902741 Macrocyclic compounds as TRK kinase inhibitors	Patent 9902741 was granted and assigned to Array Biopharma Inc. on February, 2018 by the United States Patent and Trademark Office.	Array Biopharma Inc.	Array Biopharma Inc.	United States Patent and Trademark Office	9902741	February 27, 2018
‌ US Patent 9840519 Macrocyclic compounds as TRK kinase inhibitors	Patent 9840519 was granted and assigned to Array Biopharma Inc. on December, 2017 by the United States Patent and Trademark Office.	Array Biopharma Inc.	Array Biopharma Inc.	United States Patent and Trademark Office	9840519	December 12, 2017
‌ US Patent 10137124 Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors	Patent 10137124 was granted and assigned to Array Biopharma Inc. on November, 2018 by the United States Patent and Trademark Office.	Array Biopharma Inc.	Array Biopharma Inc.	United States Patent and Trademark Office	10137124	November 27, 2018
‌ US Patent 10208024 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases	Patent 10208024 was granted and assigned to Array Biopharma Inc. on February, 2019 by the United States Patent and Trademark Office.	Array Biopharma Inc.	Array Biopharma Inc.	United States Patent and Trademark Office	10208024	February 19, 2019
‌ US Patent 7566716 Imidazopyrazines as Raf inhibitor compounds	Patent 7566716 was granted and assigned to Array Biopharma Inc. on July, 2009 by the United States Patent and Trademark Office.		Array Biopharma Inc.	United States Patent and Trademark Office	7566716	July 28, 2009
‌ US Patent 8987251 Triazolopyridine compounds as PIM kinase inhibitors	Patent 8987251 was granted and assigned to Array Biopharma Inc. on March, 2015 by the United States Patent and Trademark Office.	Array Biopharma Inc.	Array Biopharma Inc.	United States Patent and Trademark Office	8987251	March 24, 2015
‌ US Patent 10144734 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors	Patent 10144734 was granted and assigned to Array Biopharma Inc. on December, 2018 by the United States Patent and Trademark Office.	Array Biopharma Inc.	Array Biopharma Inc.	United States Patent and Trademark Office	10144734	December 4, 2018
‌ US Patent 9221841 Mitotic kinesin inhibitors and methods of use thereof	Patent 9221841 was granted and assigned to Array Biopharma Inc. on December, 2015 by the United States Patent and Trademark Office.	Array Biopharma Inc.	Array Biopharma Inc.	United States Patent and Trademark Office	9221841	December 29, 2015
‌ US Patent 7135575 P38 inhibitors and methods of use thereof	Patent 7135575 was granted and assigned to Array Biopharma Inc. on November, 2006 by the United States Patent and Trademark Office.		Array Biopharma Inc.	United States Patent and Trademark Office	7135575	November 14, 2006
‌ US Patent 10953005 Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors	Patent 10953005 was granted and assigned to Array Biopharma Inc. on March, 2021 by the United States Patent and Trademark Office.	Array Biopharma Inc.	Array Biopharma Inc.	United States Patent and Trademark Office	10953005	March 23, 2021
‌ US Patent 10189845 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors	Patent 10189845 was granted and assigned to Array Biopharma Inc. on January, 2019 by the United States Patent and Trademark Office.		Array Biopharma Inc.	United States Patent and Trademark Office	10189845	January 29, 2019
‌ US Patent 9889134 Polymorphs of ARRY-380, a selective HER 2 inhibitor and pharmaceutical compositions containing them	Patent 9889134 was granted and assigned to Array Biopharma Inc. on February, 2018 by the United States Patent and Trademark Office.	Array Biopharma Inc.	Array Biopharma Inc.	United States Patent and Trademark Office	9889134	February 13, 2018
‌ US Patent 9969727 Pyrrolopyridines as kinase inhibitors	Patent 9969727 was granted and assigned to Array Biopharma Inc. on May, 2018 by the United States Patent and Trademark Office.	Array Biopharma Inc.	Array Biopharma Inc.	United States Patent and Trademark Office	9969727	May 15, 2018

...

Results per page:

235 results

0 selected

235 results

0 selected